Back to search
FDAFDA · Food and drugs·Recall number D-0217-2017

GlucaGen HypoKit (glucagon [rDNA origin] for injection), 1 mg per vial, Single use only, Rx Only, Manufactured by: Novo Nordisk A/S 2880 Bagsvaerd, Denmark, NDC 0169-7065-15

Published December 28, 2016 · Recall initiated: September 8, 2016

Summary

FDA records drug Class I recall D-0217-2017, published December 28, 2016 and initiated September 8, 2016. Recalling firm: Novo Nordisk Inc; Status: Terminated; Reported quantity: 71,215 kits; Lot: Lots: FS6X270, FS6X296, FS6X538, FS6X597, FS6X797, FS6X875; Exp 9/30/2017. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Defective delivery system: detached needles on the syringe in the kit.

What to do

Voluntary: Firm initiated · Press Release

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Novo Nordisk Inc
Distributor
Nationwide and Worldwide
Lot
Lots: FS6X270, FS6X296, FS6X538, FS6X597, FS6X797, FS6X875; Exp 9/30/2017
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was GlucaGen HypoKit (glucagon [rDNA origin] for injection), 1 mg per vial, Single use only, Rx Only, Manufactured by: Novo Nordisk A/S 2880 Bagsvaerd, Denmark, NDC 0169-7065-15 recalled?

Yes. FDA published recall D-0217-2017 on December 28, 2016. Reported hazard: Defective delivery system: detached needles on the syringe in the kit.

What should I do if I have this product?

Voluntary: Firm initiated · Press Release